Lista de obras - Julien Dumurgier - Dominio Público Uruguay

A Novel ELISA for the Measurement of Cerebrospinal Fluid SNAP-25 in Patients with Alzheimer's Disease

scientific article published on 05 December 2018

A case series of alcoholic patients with episodic memory impairment resembling Alzheimer's disease: the use of CSF biomarkers

scholarly article by Claire Paquet et al published July 2010 in Alzheimer's and Dementia

A diagnostic scale for Alzheimer's disease based on cerebrospinal fluid biomarker profiles

artículo científico publicado en 2014

Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study

scientific article published on 20 August 2020

Alzheimer's disease cerebro-spinal fluid biomarkers: A clinical research tool sometimes useful in daily clinical practice of memory clinics for the diagnosis of complex cases

artículo científico publicado en 2016

Association of big-5 personality traits with cognitive impairment and dementia: a longitudinal study

scientific article published on 17 April 2020

Association of ideal cardiovascular health at age 50 with incidence of dementia: 25 year follow-up of Whitehall II cohort study

artículo científico publicado en 2019

Associations between baseline amyloid, sex, and APOE on subsequent tau accumulation in cerebrospinal fluid

artículo científico publicado en 2019

Biomarker profiles of Alzheimer's disease and dynamic of the association between cerebrospinal fluid levels of β-amyloid peptide and tau.

artículo científico publicado en 2019

Biomarkers and acute brain injuries: interest and limits

artículo científico publicado en 2014

Biomarkers of Alzheimer's disease in older and oldest old patients

artículo científico publicado en 2019

CSF AD BIOMARKERS IN MEMORY CLINIC PATIENTS: THE EP.L.M.FR STUDY

CSF AMYLOID-β 42/40 RATIO IN CLINICAL SETTINGS: A MULTICENTRIC STUDY

CSF Aβ 1-42 levels and glucose metabolism in Alzheimer's disease

scholarly article by Julien Dumurgier et al published July 2012 in Alzheimer's and Dementia

CSF level of β-amyloid peptide predicts mortality in Alzheimer's disease

artículo científico publicado en 2019

Cerebrospinal fluid PKR level predicts cognitive decline in Alzheimer's disease

artículo científico publicado en 2013

Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study

artículo científico publicado en 2015

Change in fast walking speed preceding death: results from a prospective longitudinal cohort study

artículo científico publicado en 2013

Cognitive function after several years of antiretroviral therapy with stable central nervous system penetration score

artículo científico publicado en 2012

Complete ophthalmoplegia complicating ophthalmic herpes zoster

artículo científico publicado en 2005

Diagnosis associated with Tau higher than 1200 pg/mL: Insights from the clinical and laboratory practice

scientific article published on 30 April 2019

Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein

artículo científico publicado en 2016

Emotional memory enhancement in respect of positive visual stimuli in Alzheimer's disease emerges after rich and deep encoding

artículo científico

Epidemiology of neurological diseases in older adults

artículo científico publicado en 2020

Exacerbated CSF abnormalities in younger patients with Alzheimer's disease

artículo científico publicado en 2013

Frontotemporal dementia is the leading cause of "true" A-/T+ profiles defined with Aβ ratio

scientific article published on 15 February 2019

GAIT SPEED AND DECLINE IN GAIT SPEED AS PREDICTORS OF INCIDENT DEMENTIA

scholarly article by A. Elbaz et al published 30 June 2017 in Innovation in Aging

Gait Speed and Decline in Gait Speed as Predictors of Incident Dementia

artículo científico publicado en 2016

Gait decline: the role of cerebral small vessel disease and biomarkers.

artículo científico publicado en 2015

Healthy behaviors at age 50 years and frailty at older ages in a 20-year follow-up of the UK Whitehall II cohort: A longitudinal study

artículo científico publicado en 2020

How many patients are eligible for disease-modifying treatment in Alzheimer's disease? A French national observational study over 5 years

scientific article published on 24 June 2019

Hypertension and lower walking speed in the elderly: the Three-City study

artículo científico publicado en 2010

IMPACT OF CEREBROSPINAL FLUID BIOMARKERS OF ALZHEIMER'S DISEASE IN CLINICAL PRACTICE: A MULTICENTRIC STUDY

Impact of cerebro-spinal fluid biomarkers of Alzheimer's disease in clinical practice: a multicentric study.

artículo científico publicado en 2013

Impact of harmonization of collection tubes on Alzheimer's disease diagnosis.

artículo científico publicado en 2013

Impact of recommendations on the initial therapy of Parkinson's disease: a population-based study in France

scientific article published on 25 May 2011

Increased cerebrospinal fluid levels of double-stranded RNA-dependant protein kinase in Alzheimer's disease

artículo científico publicado en 2012

Increased cerebrospinal fluid tau levels in logopenic variant of Alzheimer's disease

artículo científico publicado en 2014

Increased levels of cerebrospinal fluid JNK3 associated with amyloid pathology: links to cognitive decline

artículo científico publicado en 2015

Intersite variability of CSF Alzheimer's disease biomarkers in clinical setting

artículo científico publicado en 2012

Inverse association between CSF Aβ 42 levels and years of education in mild form of Alzheimer's disease: the cognitive reserve theory

artículo científico publicado en 2010

Lipid-lowering drugs associated with slower motor decline in the elderly adults

artículo científico publicado en 2013

MRI atrophy of the caudate nucleus and slower walking speed in the elderly

artículo científico publicado en 2012

Motor function in the elderly: evidence for the reserve hypothesis

artículo científico publicado en 2013

Muscle magnetic resonance imaging sensitivity does not decrease in chronic, mild, or proximal lower limb neuropathies.

artículo científico publicado en 2012

New highly sensitive rodent and human tests for soluble amyloid precursor protein alpha quantification: preclinical and clinical applications in Alzheimer's disease

artículo científico publicado en 2012

Occlusion du tronc artériel brachio-céphalique associée à un syndrome des antiphospholipides : traitement par angioplastie-stent

artículo científico publicado en 2004

Oxidative stress increases BACE1 protein levels through activation of the PKR-eIF2α pathway

artículo científico publicado en 2012

Patients with diabetes and foot ulcer present cognitive dysfunction and express fewer needs in terms of educational support

artículo científico publicado en 2017

Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia

artículo científico publicado en 2018

Primary Progressive Aphasia in the Network of French Alzheimer Plan Memory Centers

artículo científico

Pro-Apoptotic Kinase Levels in Cerebrospinal Fluid as Potential Future Biomarkers in Alzheimer's Disease

artículo científico publicado en 2015

Relationship between blood pressure, cognitive function and education level in elderly patients with diabetes: a preliminary study

artículo científico publicado en 2013

Restless legs syndrome is frequently overlooked in patients being evaluated for polyneuropathies

artículo científico publicado en 2007

Risk of cardiovascular disease morbidity and mortality in frail and pre-frail older adults: Results from a meta-analysis and exploratory meta-regression analysis.

artículo científico publicado en 2017

Screening for cognitive and affective dysfunction in patients suspected of mild cognitive impairment

artículo científico publicado en 2014

Slow walking speed and cardiovascular death in well functioning older adults: prospective cohort study

artículo científico publicado en 2009

Social inequalities in multimorbidity, frailty, disability, and transitions to mortality: a 24-year follow-up of the Whitehall II cohort study

scientific article published on 16 December 2019

Temporal T807 binding correlates with CSF tau and phospho-tau in normal elderly

artículo científico publicado en 2016

The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease

artículo científico publicado en 2016

The role of attention in emotional memory enhancement in pathological and healthy aging

artículo científico publicado en 2016

The screening of Alzheimer's patients with CSF biomarkers, modulates the distribution of APOE genotype: impact on clinical trials

artículo científico publicado en 2014

Time Orientation and 10 Years Risk of Dementia in Elderly Adults: The Three-City Study

artículo científico publicado en 2016

Utility of CSF biomarkers in psychiatric disorders: a national multicentre prospective study

artículo científico publicado en 2016

What is the clinical impact of cerebrospinal fluid biomarkers on final diagnosis and management in patients with mild cognitive impairment in clinical practice? Results from a nation-wide prospective survey in France.

artículo científico publicado en 2019

Lista de obras de Julien Dumurgier

A Novel ELISA for the Measurement of Cerebrospinal Fluid SNAP-25 in Patients with Alzheimer's Disease

A case series of alcoholic patients with episodic memory impairment resembling Alzheimer's disease: the use of CSF biomarkers

A diagnostic scale for Alzheimer's disease based on cerebrospinal fluid biomarker profiles

Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study

Alzheimer's disease cerebro-spinal fluid biomarkers: A clinical research tool sometimes useful in daily clinical practice of memory clinics for the diagnosis of complex cases

Association of big-5 personality traits with cognitive impairment and dementia: a longitudinal study

Association of ideal cardiovascular health at age 50 with incidence of dementia: 25 year follow-up of Whitehall II cohort study

Associations between baseline amyloid, sex, and APOE on subsequent tau accumulation in cerebrospinal fluid

Biomarker profiles of Alzheimer's disease and dynamic of the association between cerebrospinal fluid levels of β-amyloid peptide and tau.

Biomarkers and acute brain injuries: interest and limits

Biomarkers of Alzheimer's disease in older and oldest old patients

CSF AD BIOMARKERS IN MEMORY CLINIC PATIENTS: THE EP.L.M.FR STUDY

CSF AMYLOID-β 42/40 RATIO IN CLINICAL SETTINGS: A MULTICENTRIC STUDY

CSF Aβ 1-42 levels and glucose metabolism in Alzheimer's disease

CSF level of β-amyloid peptide predicts mortality in Alzheimer's disease

Cerebrospinal fluid PKR level predicts cognitive decline in Alzheimer's disease

Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study

Change in fast walking speed preceding death: results from a prospective longitudinal cohort study

Cognitive function after several years of antiretroviral therapy with stable central nervous system penetration score

Complete ophthalmoplegia complicating ophthalmic herpes zoster

Diagnosis associated with Tau higher than 1200 pg/mL: Insights from the clinical and laboratory practice

Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein

Emotional memory enhancement in respect of positive visual stimuli in Alzheimer's disease emerges after rich and deep encoding

Epidemiology of neurological diseases in older adults

Exacerbated CSF abnormalities in younger patients with Alzheimer's disease

Frontotemporal dementia is the leading cause of "true" A-/T+ profiles defined with Aβ ratio

GAIT SPEED AND DECLINE IN GAIT SPEED AS PREDICTORS OF INCIDENT DEMENTIA

Gait Speed and Decline in Gait Speed as Predictors of Incident Dementia

Gait decline: the role of cerebral small vessel disease and biomarkers.

Healthy behaviors at age 50 years and frailty at older ages in a 20-year follow-up of the UK Whitehall II cohort: A longitudinal study

How many patients are eligible for disease-modifying treatment in Alzheimer's disease? A French national observational study over 5 years

Hypertension and lower walking speed in the elderly: the Three-City study

IMPACT OF CEREBROSPINAL FLUID BIOMARKERS OF ALZHEIMER'S DISEASE IN CLINICAL PRACTICE: A MULTICENTRIC STUDY

Impact of cerebro-spinal fluid biomarkers of Alzheimer's disease in clinical practice: a multicentric study.

Impact of harmonization of collection tubes on Alzheimer's disease diagnosis.

Impact of recommendations on the initial therapy of Parkinson's disease: a population-based study in France

Increased cerebrospinal fluid levels of double-stranded RNA-dependant protein kinase in Alzheimer's disease

Increased cerebrospinal fluid tau levels in logopenic variant of Alzheimer's disease

Increased levels of cerebrospinal fluid JNK3 associated with amyloid pathology: links to cognitive decline

Intersite variability of CSF Alzheimer's disease biomarkers in clinical setting

Inverse association between CSF Aβ 42 levels and years of education in mild form of Alzheimer's disease: the cognitive reserve theory

Lipid-lowering drugs associated with slower motor decline in the elderly adults

MRI atrophy of the caudate nucleus and slower walking speed in the elderly

Motor function in the elderly: evidence for the reserve hypothesis

Muscle magnetic resonance imaging sensitivity does not decrease in chronic, mild, or proximal lower limb neuropathies.

New highly sensitive rodent and human tests for soluble amyloid precursor protein alpha quantification: preclinical and clinical applications in Alzheimer's disease

Occlusion du tronc artériel brachio-céphalique associée à un syndrome des antiphospholipides : traitement par angioplastie-stent

Oxidative stress increases BACE1 protein levels through activation of the PKR-eIF2α pathway

Patients with diabetes and foot ulcer present cognitive dysfunction and express fewer needs in terms of educational support

Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia

Primary Progressive Aphasia in the Network of French Alzheimer Plan Memory Centers

Pro-Apoptotic Kinase Levels in Cerebrospinal Fluid as Potential Future Biomarkers in Alzheimer's Disease

Relationship between blood pressure, cognitive function and education level in elderly patients with diabetes: a preliminary study

Restless legs syndrome is frequently overlooked in patients being evaluated for polyneuropathies

Risk of cardiovascular disease morbidity and mortality in frail and pre-frail older adults: Results from a meta-analysis and exploratory meta-regression analysis.

Screening for cognitive and affective dysfunction in patients suspected of mild cognitive impairment

Slow walking speed and cardiovascular death in well functioning older adults: prospective cohort study

Social inequalities in multimorbidity, frailty, disability, and transitions to mortality: a 24-year follow-up of the Whitehall II cohort study

Temporal T807 binding correlates with CSF tau and phospho-tau in normal elderly

The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease

The role of attention in emotional memory enhancement in pathological and healthy aging

The screening of Alzheimer's patients with CSF biomarkers, modulates the distribution of APOE genotype: impact on clinical trials

Time Orientation and 10 Years Risk of Dementia in Elderly Adults: The Three-City Study

Utility of CSF biomarkers in psychiatric disorders: a national multicentre prospective study

What is the clinical impact of cerebrospinal fluid biomarkers on final diagnosis and management in patients with mild cognitive impairment in clinical practice? Results from a nation-wide prospective survey in France.

Diagnosis associated with Tau higher than 1200 pg/mL: Insights from the clinical and laboratory practice